IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 5,280.00
-160.00 (-2.94%)
May 20, 2026, 3:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 74.01 billion as of May 20, 2026. Its market cap has decreased by -44.01% in one year.
Market Cap
74.01B
Enterprise Value
53.78B
Revenue
5.33B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,280.00
Market Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 74.01B, a decrease of -85.31%. That is a compound annual growth rate of -59.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 76.26B | -44.99% |
| Dec 30, 2025 | 138.64B | -7.14% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Macrogen | 148.20B |
| GeneOne Life Science | 148.16B |
| MedPacto | 141.38B |
| Vaxcell-Bio Therapeutics | 137.68B |
| Amicogen | 127.03B |
| ENCell | 126.08B |
| iNtRON Biotechnology | 97.05B |
| Prestige BioPharma | 88.10B |